ASCO 2015 | Emerging immunotherapies for kidney cancer

Thomas Powles

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Thomas Powles, MBBS, MRCP, MD, from Barts Cancer Institute, Queen Mary University of London, London, UK, provides an overview of promising novel immunotherapeutic strategies that are currently under investigation for the treatment of patients with kidney cancer.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter